Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Thatcher

Showing results (141-150 of 289) with videos related to

Pageof 29
Sort By:
Clinical and Experimental Immunology|March 1, 1981
Human lymphocyte traffic assessed by indium-111 oxine labelling: clinical observationsJ Wagstaff, C Gibson, N Thatcher, et al.
British Journal of Clinical Pharmacology|July 1, 1990
The effect of age on the pharmacokinetics of ifosfamideM J Lind, J M Margison, T Cerny, et al.
The British Journal of Surgery|February 1, 1986
Randomized study of Corynebacterium parvum adjuvant therapy following surgery for (stage II) malignant melanomaN Thatcher, A Mene, S S Banerjee, et al.
Cancer|January 15, 1994
Metastatic carcinoma of uncertain primary site: a retrospective review of 57 patients treated with vincristine, doxorubicin, cyclophosphamide (VAC) or VAC alternating with cisplatin and etoposide (VAC/PE)E S de Campos, L P Menasce, J Radford, et al.
Lancet (London, England)|June 23, 1990
Cost-effectiveness of weekly and fortnightly subcutaneous erythropoietinM Thomas, B M Saker, G N Thatcher, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1986
A phase II study of cyclophosphamide as a 24-hr infusion in advanced non-small cell lung cancerD B Smith, N Thatcher, W P Steward, et al.
The Journal of Pathology|September 1, 1990
DNA analysis by flow cytometry in malignant pleural mesothelioma: relationship to histology and survivalH Dazzi, N Thatcher, P S Hasleton, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1991
Recombinant human GM-CSF in small cell lung cancer: a phase I/II studyH Anderson, H Gurney, N Thatcher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1995
Multicyclic, dose-intensive chemotherapy supported by sequential reinfusion of hematopoietic progenitors in whole bloodR Pettengell, P J Woll, N Thatcher, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1994
Phase II study of gemcitabine (2',2'-difluorodeoxycytidine) given as a twice weekly schedule to previously untreated patients with non-small cell lung cancerB Lund, M Ryberg, P M Petersen, et al.
Pageof 29

Showing results (141-150 of 289) with videos related to

Sort By:
Pageof 29
Clinical and Experimental Immunology|March 1, 1981
Human lymphocyte traffic assessed by indium-111 oxine labelling: clinical observationsJ Wagstaff, C Gibson, N Thatcher, et al.
British Journal of Clinical Pharmacology|July 1, 1990
The effect of age on the pharmacokinetics of ifosfamideM J Lind, J M Margison, T Cerny, et al.
The British Journal of Surgery|February 1, 1986
Randomized study of Corynebacterium parvum adjuvant therapy following surgery for (stage II) malignant melanomaN Thatcher, A Mene, S S Banerjee, et al.
Cancer|January 15, 1994
Metastatic carcinoma of uncertain primary site: a retrospective review of 57 patients treated with vincristine, doxorubicin, cyclophosphamide (VAC) or VAC alternating with cisplatin and etoposide (VAC/PE)E S de Campos, L P Menasce, J Radford, et al.
Lancet (London, England)|June 23, 1990
Cost-effectiveness of weekly and fortnightly subcutaneous erythropoietinM Thomas, B M Saker, G N Thatcher, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1986
A phase II study of cyclophosphamide as a 24-hr infusion in advanced non-small cell lung cancerD B Smith, N Thatcher, W P Steward, et al.
The Journal of Pathology|September 1, 1990
DNA analysis by flow cytometry in malignant pleural mesothelioma: relationship to histology and survivalH Dazzi, N Thatcher, P S Hasleton, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1991
Recombinant human GM-CSF in small cell lung cancer: a phase I/II studyH Anderson, H Gurney, N Thatcher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1995
Multicyclic, dose-intensive chemotherapy supported by sequential reinfusion of hematopoietic progenitors in whole bloodR Pettengell, P J Woll, N Thatcher, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1994
Phase II study of gemcitabine (2',2'-difluorodeoxycytidine) given as a twice weekly schedule to previously untreated patients with non-small cell lung cancerB Lund, M Ryberg, P M Petersen, et al.
Pageof 29